← All stocks

ILLUMINA, INC.

ILMN Net selling
CIK 0001110803 #631 in the set updated 17 Sep 2026
Bought (120 mo)
$2.57M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$884.75M
$3.01M on a plan · $152.63M straight out of an exercise
Sold at will
$729.11M
651 of 898 sales
Net
−$882.18M
−$726.54M against sales at will

By person

52 insiders · 915 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meister Keith A.
Director
$591.13M (93)
−$591.13M
1,811,040
1.20%
$396.94M
−62.8%
FLATLEY JAY T
Director
$139.11M (126)
−$139.11M
152,433
0.1009%
$33.41M
−62.4%
Ronaghi Mostafa
SVP, Entrepreneurial Devlopmt
$45.40M (81) scheduled
−$45.40M
80,162
0.0531%
$17.57M
+37.2%
deSouza Francis A
President and CEO
$26.33M (149)
−$26.33M
120,992
0.0801%
$26.52M
+100.2%
OSTADAN OMEAD
SVP Mktg, Prod & Strat Plan
$8.97M (31)
−$8.97M
17,172
0.0114%
$3.76M
−17.4%
Van Oene Mark
SVP Chief Commercial Officer
$8.31M (38) scheduled
−$8.31M
16,575
0.0110%
$3.63M
−14.7%
TOUSI SUSAN H
SVP, Chief Commercial Officer
$7.72M (47)
−$7.72M
89,267
0.0591%
$19.57M
+3.5%
Dadswell Charles
SVP, General Counsel
$7.54M (55)
−$7.54M
26,790
0.0177%
$5.87M
+116.4%
Aravanis Alexander
SVP, Chief Technology Officer
$6.52M (24)
−$6.52M
12,587
0.0083%
$2.76M
+7,261%
EPSTEIN ROBERT S
Director
$6.00M (20) scheduled
−$6.00M
22,139
0.0147%
$4.85M
+167.5%
RAGUSA ROBERT P
SVP, Global Quality & Ops
$5.91M (24)
−$5.91M
9,617
0.0064%
$2.11M
−12.3%
Stapley Marc
EVP Strategy & Corp Developmt
$5.90M (62)
−$5.90M
6,957
0.0046%
$1.52M
−63.9%
BOWMAN A BLAINE
Director
$5.20M (35) scheduled
−$5.20M
15,946
0.0106%
$3.50M
+1.5%
EASTHAM KARIN
Director
$4.30M (21) scheduled
−$4.30M
10,049
0.0067%
$2.20M
−15.7%
Hoyt Aimee L
SVP, Chief People Officer
$4.21M (25)
−$4.21M
8,314
0.0055%
$1.82M
+953.7%
Bouchard Michel
Chief Accounting Officer
$2.85M (9)
−$2.85M
9,538
0.0063%
$2.09M
−55.1%
SAMAD SAM
SVP and CFO
$2.32M (7)
−$2.32M
11,297
0.0075%
$2.48M
Thaysen Jacob
Chief Executive Officer
$1.99M (10)
+$1.99M
109,073
0.0722%
$23.91M
+14,521%
Febbo Phillip G.
SVP Chief Medical Officer
$1.72M (8)
−$1.72M
14,786
0.0098%
$3.24M
+747.8%
ARNOLD FRANCES
Director
$1.20M (5)
−$1.20M
20,907
0.0138%
$4.58M
+125.7%
MCGINNIS KAREN K
VP, Chief Accounting Officer
$1.18M (5)
−$1.18M
1,538
0.0010%
$337.10K
+308.0%
BRADBURY DANIEL
Director
$751.13K (13) scheduled
−$751.13K
15,324
0.0101%
$3.36M
−6.9%
Davies Scott M
Chief Legal Officer
$531.27K (5) scheduled
−$531.27K
20,338
0.0135%
$4.46M
+46.5%
Leckman Patricia
SVP, Chief People Officer
$529.72K (9) scheduled
−$529.72K
21,259
0.0141%
$4.66M
+127.1%
Dhingra Ankur
SVP, Chief Financial Officer
$495.38K (1)
+$495.38K
34,264
0.0227%
$7.51M
+19,258%
DORSA CAROLINE
Director
$450.00K (1)
−$450.00K
15,754
0.0104%
$3.45M
+29,625%
Wedel Christensen Jakob
SVP, Strategy/Corp Development
$366.14K (3) scheduled
−$366.14K
14,023
0.0093%
$3.07M
+300.9%
Ericksen Scott D
VP, Chief Accounting Officer
$305.15K (2) scheduled
−$305.15K
14,446
0.0096%
$3.17M
+113.5%
Gottlieb Scott
Director
$84.63K (2)
+$84.63K
14,795
0.0098%
$3.24M
+27,815%
ORPIN TRISTAN
EVP Clinical Genomics
118,259
0.0783%
$25.92M
−0.6%
Cunningham Everett
SVP, Chief Commercial Officer
41,942
0.0278%
$9.19M
+18,377%
Barnard Steven
SVP, Chief Technology Officer
40,927
0.0271%
$8.97M
+104.7%
Pegels Kevin Carl
Chief of Global Operations
29,038
0.0192%
$6.36M
+415.9%
GOSWAMI JOYDEEP
SVP, Chief Financial Officer
24,478
0.0162%
$5.37M
+6,681%
SCHILLER PHILIP W
Director
22,220
0.0147%
$4.87M
+830.5%
Coletti Julie Ann
Chief Legal Officer
18,763
0.0124%
$4.11M
Rollins Carissa
SVP, Chief Information Officer
18,447
0.0122%
$4.04M
+2,040%
Reeves Kathryne Gambrell
SVP, Chief Marketing Officer
17,965
0.0119%
$3.94M
HENRY CHRISTIAN O
EVP & Chief Commercial Officer
17,531
0.0116%
$3.84M
−7.6%
SIEGEL SUSAN E
Director
16,535
0.0110%
$3.62M
+31,098%
GUTHART GARY S
Director
16,430
0.0109%
$3.60M
+23,041%
Ullem Scott B.
Director
11,030
0.0073%
$2.42M
+20,711%
THOMPSON JOHN WENDELL
Director
10,162
0.0067%
$2.23M
+19,074%
Frank John Edward
Chief Public Affairs Officer
9,166
0.0061%
$2.01M
RICHO ANNA
Director
8,527
0.0056%
$1.87M
+15,989%
Hampton Malcolm Garret
SVP Clinical Genomics Group
6,598
0.0044%
$1.45M
+86.8%
Sullivan Michael C
Chief Commercial Officer
4,503
0.0030%
$986.97K
MACMILLAN STEPHEN P
Director
4,129
0.0027%
$904.99K
KING DAVID P
Director
2,072
0.0014%
$454.14K
TORRES JOSE
VP, Chief Accounting Officer
1,748
0.0012%
$383.13K
+3,078%
Skovronsky Daniel
Director
1,674
0.0011%
$366.91K
Teno Andrew
Director
1,532
0.0010%
$335.78K
Insider
Date
Role
Action
Shares
Price
Amount
Meister Keith A.
12 May 2026
Director
Exercised, kept indirect
255,378
$102.82
$26.26M
Meister Keith A.
11 May 2026
Director
Exercised, kept indirect
79,568
$102.82
$8.18M
Meister Keith A.
7 May 2026
Director
Exercised, kept indirect
9,236
$102.82
$949.65K
EPSTEIN ROBERT S
25 May 2023
Director
Exercised, kept
7,600
$71.09
$540.28K
Showing 250 of 915 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 846
Amendments (4/A) skipped 5
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 221
Sales at will 651
Transactions with no price 0
Shares from compensation/vesting 3,207,825
Sales filed before the plan box existed 560
History held since 8 Sep 2016